card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

 card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

 card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

 card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

 card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services
WE'RE HIRING

Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search jobs website-featured_jpg-2213_cheerful-young-colleagues-using-laptop
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download card-3242_Scientist using tablet while colleagues working behind
3233_discovery

Discovery Sciences

Our labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
3235_biomarkers

Biomarker analysis

a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
2768_CentralLaboratory

Central laboratories

Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
3253_bioa

Bioanalytical services

One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
182_genomics-1

Genomics

We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.
3214_vaccines

Vaccines

Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
card-3242_Scientist using tablet while colleagues working behind

Digital innovation

We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
2768_therapeutic_expertise

Therapeutic expertise
Contact Us
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Vaccine Credentials

respiratory-vaccines-header

• Seasonal and Pandemic Influenza
• Hemophilus influenzae B
• Respiratory Syncytial virus 
• Neisseria meningitidis
• Streptococcus pneumoniae
• Bordetella pertussis
• Corynebacterium diphtheriae
• Rhinovirus
• SARS-CoV-1
• SARS-CoV-2
• MERS
• hMPV 
• PIV

other-infectious-diseases-vaccines-header

  • Human papilloma virus
    • Adenovirus
  • Adeno-associated virus (AAV)
  • Coxsackie virus
  • Measles
  • Mumps
  • Rubella
  • Varicella Zoster
  • Tetanus
  • Staphylococcus aureus
  • Streptococcus agalactiae (GBS)
  • Lymphocytic choriomeningitis
  • mammarenavirus (LCMV)
  • Poliovirus
  • Vaccinia

enteric-vaccines-header

• Escherichia coli
• Shigella spp.
• Clostridium difficile
• Rotavirus
• Salmonella typhimurium

sexually-transmitted-vaccines-header

• Cytomegalovirus
• Herpes simplex virus -1/-2
• Hepatitis A, B, C
• Epstein Barr Virus
• HIV

vector-zoonotic-vaccines-header

• Chikungunya
• Zika
• Dengue
• Ebola
• Malaria
• West Nile
• Tick-borne encephalitis virus
• Yellow Fever
• Nipah

SARS-CoV Variants (VOCs/VOIs)
Variant Lineage Pseudovirus Neutralization Assay (PNA) ELISA
D614 NA X (validated) X (validated)
RBD NA NA X (validated)
Nucleocapsid NA NA X (validated)
D614G B.1 X (validated) X (Ag available)
Alpha B.1.1.7 X (optimized) X (Ag available)
Beta B.1.351 X (validated) X (Ag available)
Delta B.1.617.2 X (validated) X (Ag available)
Delta+ B.1.617.2 + K714N X (optimized) X (Ag available)
Epsilon B.1.429 X (optimized) X (Ag available)
Eta B.1.525 X (optimized) NA
Gamma P.1 X (optimized) X (Ag available)
Iota-1 and 2 B.1.526 X (optimized) X (Ag available)
Kappa B.1.617.1 X (optimized) On going
Lambda C.37 X (optimized) NA
Mu B.1.621 X (optimized) NA
Omicron BA.1/B.1.1.529.1 X (validated) X (qualified)
Omicron BA.2/B.1.1.529.2 X (validated) On going
Omicron BA.4/5; B.1.1.529.4/5 X (validated) On going
Omicron BA.2.75 X (optimized) On going
Theta P.3 X (optimized) NA
XBB.1 BA.2.10.1 X (optimized) On going
XBB 1.5 BA.2.10.5 X (optimized) On going
XBB 1.16 Close related to XBB 1.5 XBB 1.5 validated On going
XBB 1.9.1 Close related to XBB 1.5 X (optimized) On going
XBB 1.9.2 Close related to XBB 1.5 X (optimized) On going
BQ.1 BA.5 derivative X (optimized) On going
CH.1.1 Derivative Delta X (optimized) On going
Pirola BA.2.86 On going On going
SARS-CoV-1 NA X (optimized) On going
MERS NA X (optimized) On going

 

Various Pathogens
Pathogens Assay type Validation level
SARS-CoV-2 Spike (peptides) 14-colors ICS Qualified
SARS-CoV-2 Spike (peptides) IFNg ELISPOT Qualified
SARS-CoV-2 Spike (peptides) IFNg/IL-5 ELISPOT Qualified
RSV A2, A-Long, B µneutralization Qualified
Chikungunya virus µneutralization Qualified
Chikungunya virus ELISA Qualified
Anti-Pertactin ELISA Validated
Anti-Tetanus Toxoid ELISA Qualified
Anti-Filamentous Haemagglutinin (FHA) ELISA Qualified
Pertussis SBA Qualified
Anti-Pertussis ELISA Qualified
Anti-Diphteria Toxoid ELISA Qualified
Anti-VZV ELISA Qualified
Anti-Rubella ELISA Validated
Anti-Measles ELISA Validated
Anti-Mumps ELISA Validated
Anti-Haemophilus Influenza B (HiB) ELISA Validation ongoing
Anti-Hepatitis B (HepB) HBsAg ELISA Validation ongoing
Anti-Hepatitis A (HepA) ELISA Validation ongoing
24-plex Pneumococcal Polysaccharide Serotypes MSD Validation ongoing
24-plex Pneumococcal Polysaccharide Serotypes 24 WHO ELISAs Validation ongoing
24-Plex Pneumococca Multiplex Opsonophagocytosis Assay (MOPA) Qualification ongoing